Skip to search.
 TSX Up 0.87% TSX Ventures Up 0.73%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
18.36 Down 0.14(0.76%) May 21, 4:00PM EDT
Add to Portfolio
Prev Close:18.50
Open:18.31
Bid:14.50 x 300
Ask:N/A
1y Target Est:23.50
Beta:0.35
Earnings Date:Aug 5 - Aug 10 (Est.)
Day's Range:18.04 - 18.50
52wk Range:11.87 - 19.75
Volume:169,772
Avg Vol (3m):169,429
Market Cap:631.55M
P/E (ttm):655.71
EPS (ttm):0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OSIRDown 0.76%631.55M
ABTUp 0.41%73.46B
BIIBUp 0.04%94.36B

Key Statistics

Forward P/E (1 yr):28.25
P/S (ttm):8.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.41
Quarterly EPS Est (Jun-15) :0.06
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback